Perrottetinene

Last updated
Perrottetinene
Perrottetinene.svg
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • (6aS,10aR)- 6,6,9-trimethyl- 3-(2-phenylethyl)- 6a,7,8,10a-tetrahydrobenzo[c]chromen- 1-ol
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
Formula C24H28O2
Molar mass 348.486 g·mol−1
3D model (JSmol)
  • CC1=C[C@H]2c3c(cc(cc3OC([C@H]2CC1)(C)C)CCc4ccccc4)O
  • InChI=1S/C24H28O2/c1-16-9-12-20-19(13-16)23-21(25)14-18(15-22(23)26-24(20,2)3)11-10-17-7-5-4-6-8-17/h4-8,13-15,19-20,25H,9-12H2,1-3H3/t19-,20+/m1/s1
  • Key:DYHMKBLKWFFFSZ-UXHICEINSA-N
   (verify)

Perrottetinene is a naturally occurring cannabinoid compound found in liverworts from the family Radulaceae native to Japan, New Zealand and Costa Rica, namely Cladoradula perrottetii , Radula marginata and Radula laxiramea, [1] [2] along with a number of similar compounds. [3] [4] Its chemical structure closely resembles that of THC, the main active component of marijuana but with a cis rather than trans conformation and a bibenzyl tailchain instead of pentyl. [5] The absolute configuration of perrottetinene was established in 2008 by an enantioselective total synthesis. [6]

Contents

Pharmacology

In 2018, a study showed that perrottetinene is mild to moderately psychoactive through activation of the cannabinoid receptor 1. (-)-cis-Perrottetinene was found to have a binding affinity of 481 nM at CB1 and 225 nM at CB2, while the unnatural (-)-trans-perrottetinene was found to more active with binding affinities of 127 nM at CB1 and 126 nM at CB2, both acting as partial agonists. In terms of binding affinity, this study found cis-perrottetinene to be over 22 times weaker than delta-9-THC. The same study also reported significantly reduced prostaglandin D2 and E2 brain concentrations in mice after perrottetinene administration. [7]

Perrottetinene is structurally related to machaeriol A and other machaeriols found in Machaerium species. [8]

See also

References

  1. ↑ Saygin D, Tabib T, Bittar HE, Valenzi E, Sembrat J, Chan SY, et al. (1999-04-01). "Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension". Pulmonary Circulation. 10 (1): 147–150. doi: 10.1515/znc-1999-3-401 . PMC   7052475 . PMID   32166015.
  2. ↑ Kumar A, Premoli M, Aria F, Bonini SA, Maccarinelli G, Gianoncelli A, et al. (June 2019). "Cannabimimetic plants: are they new cannabinoidergic modulators?". Planta. 249 (6): 1681–1694. doi:10.1007/s00425-019-03138-x. PMID   30877436. S2CID   253886986.
  3. ↑ Toyota M, Kinugawa T, Asakawa Y (1994). "Bibenzyl cannabinoid and bisbibenzyl derivative from the liverwort Radula perrottetii". Phytochemistry. 37 (3): 859–862. doi:10.1016/S0031-9422(00)90371-6.
  4. ↑ Toyota M, Shimamura T, Ishii H, Renner M, Braggins J, Asakawa Y (October 2002). "New bibenzyl cannabinoid from the New Zealand liverwort Radula marginata". Chemical & Pharmaceutical Bulletin. 50 (10): 1390–1392. doi: 10.1248/cpb.50.1390 . PMID   12372871.
  5. ↑ Reis MH, Antunes D, Santos LH, Guimarães AC, Caffarena ER (December 2020). "Shared Binding Mode of Perrottetinene and Tetrahydrocannabinol Diastereomers inside the CB1 Receptor May Incentivize Novel Medicinal Drug Design: Findings from an in Silico Assay". ACS Chemical Neuroscience. 11 (24): 4289–4300. doi:10.1021/acschemneuro.0c00547. PMID   33201672. S2CID   227038959.
  6. ↑ Song Y, Hwang S, Gong P, Kim D, Kim S (January 2008). "Stereoselective total synthesis of (-)-perrottetinene and assignment of its absolute configuration". Organic Letters. 10 (2): 269–271. doi:10.1021/ol702692q. PMID   18085788.
  7. ↑ Chicca A, Schafroth MA, Reynoso-Moreno I, Erni R, Petrucci V, Carreira EM, Gertsch J (October 2018). "Uncovering the psychoactivity of a cannabinoid from liverworts associated with HAVOK". Science Advances. 4 (10) eaat2166. Bibcode:2018SciA....4.2166C. doi:10.1126/sciadv.aat2166. PMC   6200358 . PMID   30397641.
  8. ↑ "Machaeriol A".


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.